Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Our volunteers generously give us their time, skills and experience to tell people about our work, and to help us raise vital funds for research into better treatments and ultimately a cure for T1D.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Breakthrough T1D appears on Piccadilly Lights alongside EE72 film starring Kate Moss
The film premiered in London’s iconic Piccadilly Circus, delivering a ten-minute cinematic takeover of Europe’s largest digital canvas, bringing Breakthrough T1D’s mission to one of the world’s most high-profile advertising destinations. The charity’s logo appears alongside the film in recognition of its vital work accelerating research, improving lives and advocating for everyone living with type 1 diabetes. Breakthrough T1D is close to the heart of Kate Moss, whose daughter, Lila Moss, has been an advocate for the type 1 diabetes community.
EE72 is a media and entertainment company co-founded by Edward Enninful OBE and Akua Enninful, designed for the future of storytelling. By bridging the gap between high-fashion editorial and immersive digital experiences, the company is redefining how luxury content is consumed. The film premiere serves as an extension of the current Spring 2026 issue of the company’s quarterly magazine 72, where Moss stars in a cover story shot by Knight, translating Knight’s vision into a large-scale public experience.
Coinciding with this screening, EE72 has launched a limited-edition A2 poster of the Spring 2026 cover of 72, available to purchase at ee72.com from Friday 15 May 2026. Photographed by Nick Knight and featuring Kate Moss, this collector’s piece includes Kate’s printed handwritten signature. The poster will be available for two weeks. Profits from sales of the poster will benefit Breakthrough T1D.
Orna Joseph, Deputy Director of Brand at Breakthrough T1D, said: “To have our mission featured on Piccadilly Lights as part of this beautiful creative work is truly extraordinary. For the millions of people affected by type 1 diabetes, moments like this help shine a spotlight on a condition that is often misunderstood. We’re deeply grateful to Kate Moss, Nick Knight and EE72 for using such a globally visible platform to help raise awareness of type 1 diabetes and to support the research that brings us closer to cures.”
Akua Enninful, Co-Founder & CEO, EE72 said: “At its core, EE72 is driven by a very simple desire to create moments that actually make people feel something. We talk about the ‘heartbeat’ of the company, and to me, that is the energy you feel when culture becomes a shared experience rather than something kept behind closed doors. Seeing Nick and Kate’s collaboration take over such an iconic public space is exactly why we started EE72; it’s about bringing the extraordinary to the everyday.”
Get to know the people who guide Breakthrough T1D, taking charge of how our organisation is run and ensuring we’re heading in the right direction.
Find out about our work to make T1D treatments available to everyone who needs or wants them.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.
If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
